Published in Cancer Weekly, January 9th, 2007
The results from these studies, conducted by EntreMed researchers, were presented at the 48th Annual Meeting of the American Society of Hematology in Orlando, Florida.
Panzem is currently being evaluated in Phase 1 and Phase 2 oncology clinical trials, including multiple myeloma. In...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-01-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.